About
BlueWillow Biologics is a clinical-stage biotechnology company developing intranasal vaccines and adjuvant delivery platforms to prevent infectious diseases such as influenza, using its NanoVax technology platform.
Explore BlueWillow Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.